Cellectis bioresearch, a subsidiary of Cellectis Group, the genome engineering specialist, has signed a collaboration agreement with
Stemgent, Inc. to provide research services that combines mRNA reprogramming technology and genome engineering.The partnership ...
[Published PharmaBiz - Mar 09 2013]